JYNT · JOINT Corp · Metrics
$7.25
-0.01 (-0.14%)
At close · Oct 29
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$102.68M
Shares
14.14M
Volume · Oct 29
15.49K
Avg daily vol (3M)
75.49K
JYNT metrics
94 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$7.26
Market cap
$102.68M
Price action
20 metricsPrice change (1W)
+1.3%
Price change (30D)
-6.3%
Price change (3M)
-12.9%
Price change (6M)
-18.1%
Price change (YTD)
-16.7%
Price change (1Y)
-12.5%
Trailing year
Price change (5Y)
-91.5%
52-week high
$10.53
52-week low
$6.90
Change from 52-week high
-31.1%
Change from 52-week low
+5.2%
Annualized volatility
35.7%
Annualized volatility (3M)
29.1%
Beta
0.6
RSI (14D)
44.5
Price vs SMA 50
-7.2%
Price vs SMA 200
-15.8%
Avg volume (3M)
75,485
Relative volume
0.5
Average dollar volume
$604,354
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
14.14M
Valuation
12 metricsP / E (TTM)
26.9
Trailing earnings · reciprocal yield 3.7%
PEG ratio
0.1
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.7×
reciprocal yield 57.4%
P / book
6.4
reciprocal yield 15.5%
FCF yield
4.1%
TTM · current market cap
Buyback yield
12.9%
P / FCF
24.1
reciprocal yield 4.1%
P / operating cash flow
18.9
reciprocal yield 5.3%
Earnings yield
3.7%
Historical valuation
8 metricsP / E historical average (3Y)
44.6×
reciprocal yield 2.2%
P / E historical average (5Y)
182.6×
reciprocal yield 0.5%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
12.9%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
2026-11-05
Last earnings
2026-08-06
Profitability
9 metricsGross margin
81.8%
Operating margin
2.4%
Trailing 12 months
Net margin
6.5%
Gross profit (TTM)
$47.87M
Operating profit (TTM)
$1.41M
Net income (TTM)
$3.80M
Trailing 12 months
Diluted EPS (TTM)
$0.27
FCF margin
7.2%
Effective tax rate
1.6%
Growth
11 metricsRevenue growth YoY
+14.4%
Year over year
Net income growth YoY
+599.4%
Revenue (TTM)
$58.55M
Trailing 12 months
EPS growth YoY
+400.0%
Shares change YoY
-7.5%
Year over year · fewer shares
Revenue CAGR (3Y)
-18.5%
Revenue CAGR (5Y)
-1.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
-26.7%
FCF CAGR (3Y)
-47.5%
FCF CAGR (5Y)
-47.0%
Quality
14 metricsReturn on equity
24.0%
Return on assets
7.4%
Debt / equity
—
Current ratio
1.8
EBITDA (TTM)
$3.12M
Free cash flow (TTM)
$4.23M
Quick ratio
1.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$22.16M
Total assets
$51.63M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$5.39M
Capital expenditures (TTM)
$1.16M
R&D (TTM)
—
SG&A (TTM)
$46.23M
Stock compensation (TTM)
$1.38M
R&D / revenue
—
Stock compensation / revenue
2.3%
Ownership (13F)
9 metrics13F filers
84
13F filer change QoQ
-2
Institutional ownership
69.5%
Conviction holders (share of 13F filers)
2.4%
Crowding (high-turnover and private-fund holders)
48.6%
Private-fund adviser ownership
45.4%
Active holders' share change QoQ
+3.4%
Holder tenure
17.9
Price vs estimated holder cost
-15.0%
Ownership (registered funds)
1 metricsIndex-fund ownership
7.2%
Short interest
3 metricsShort interest
2.5%
Latest settlement · 4.1 days to cover
Days to cover
4.1d
Short-squeeze score
42 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—